CONNECT WITH US
Tech

Tech

A New Benchmark for De-Aging Comes From Slowly Turning Back Cells’ Clocks

Wired logo

Published on

Add as a preferred source on Google
A New Benchmark for De-Aging Comes From Slowly Turning Back Cells’ Clocks

Scientists have long known how to make cells younger—at least in the sense that adult cells can be converted into pluripotent stem cells very similar to those found in embryos. While this capability has been foundational for biological research, these methods aren’t viable for anti-aging technologies, for a few reasons.

“You don't want to have a pluripotent cell in your body, because it can become all types of cells,” says Oliver Brüstle, a professor who studies stem cells at Germany’s Bonn University.

Additionally, the few key genes involved in the stem cell conversion process can drive the formation of cancer if left active. That’s why Brüstle and his team have looked for other ways of de-aging cells without going through a pluripotent state. In their recent study published in Aging Cell, the researchers started with blood cells from people of various ages, including an infant and a 101-year-old donor.

They guided these cells into a younger state but not all the way toward becoming embryonic-like stem cells. And as this transformation progressed, the chemical signals in the DNA that help estimate a cell’s age also changed. In less than two months of reprogramming, one biomarker in particular was set back as far as 60 years.

Aging continued to reverse even when the scientists drastically reduced the cells’ ability to multiply. Therefore, the apparent rejuvenation can’t be explained solely by the fact that the cells were dividing and producing new cells over and over again. However, the mechanism that did erase these signs of aging is still unclear.


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.